Provided are substituted quinuclidine compounds, pharmaceutical compositions comprising such compounds, and methods of modulating α7 nicotinic acetylcholine receptors and treating neurological disorders using such compounds.
-
Paragraph 0388
(2016/02/29)
More Articles about upstream products of 128717-78-2